Luminex Corporation (NASDAQ: LMNX) today announced that it has received CE-IVD marking for its NxTAG® Respiratory Pathogen Panel. The Panel detects 21 clinically-relevant viral and bacterial ...
SANTA FE SPRINGS, Calif., December 22, 2025--(BUSINESS WIRE)--Applied BioCode, a leader in innovative molecular diagnostic solutions, announced today the submission of a new nucleic acid extraction ...
(RTTNews) - Luminex Corp. (LMNX) said it has received Emergency Use Authorization from the FDA for a new expanded version of NxTAG Respiratory Pathogen Panel that includes the SARS-CoV-2 virus for ...
AUSTIN, Texas, March 4, 2021 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) ...
Alpharetta, Ga.-based Provista Diagnostics, a clinical diagnostics lab owned by medical diagnostics company Todos Medical, cleared all necessary hurdles to begin producing its new respiratory test ...
Please provide your email address to receive an email when new articles are posted on . Qiagen’s respiratory panel can detect 21 viral and bacterial pathogens that can cause upper respiratory ...
CORALVILLE, Iowa--(BUSINESS WIRE)--To meet customer demand for a multiplexed, multiple respiratory disease target panel that provides comprehensive genome coverage, Integrated DNA Technologies (IDT) ...
Routine use of rapid respiratory virus testing in the emergency department (ED) appears to show limited benefit among patients with signs and symptoms of acute respiratory infection (ARI), according ...
Please provide your email address to receive an email when new articles are posted on . The American Thoracic Society issued a new clinical practice guideline that addresses the use of nucleic ...
Applied BioCode, a leader in innovative molecular diagnostic solutions, announced today the submission of a new nucleic acid extraction claim for the KingFisher™ Flex Nucleic Acid Purification System ...
(RTTNews) - Luminex Corp. (LMNX) said it has received Emergency Use Authorization from the FDA for a new expanded version of NxTAG Respiratory Pathogen Panel that includes the SARS-CoV-2 virus for ...